Zygoma 和 Pteryx 植入物市场——增长、趋势和预测 (2023-2028)

预计在预测期内，颧骨和翼状骨植入物市场的复合年增长率为 5.9%。

COVID-19 的爆发已成为牙科面临的重大挑战。 对感染病毒的恐惧以及牙科手术程序和在线咨询的推迟是导致牙科诊所访问量下降的主要因素。 例如，2020 年 3 月，美国牙科协会 (ADA) 决定将选择性牙科护理推迟到牙科诊所，并用患者代替仅限急诊的牙科护理，以避免给医院急诊科带来负担。建议提供服务。 这导致对颧骨和翼骨植入物的需求下降，对整个市场产生了重大影响。 但是，随着 COVID-19 病例数量下降和服务恢復，预计在未来两到三年内将从这种影响中恢復过来。

口腔疾病患病率上升、口腔健康意识增强以及对美容牙科的需求增加是预计将推动颧骨和翼状骨植入物市场增长的关键因素。 例如，根据世卫组织 2022 年 11 月的估计，口腔疾病影响全球近 35 亿人，其中四分之三的受影响人口生活在中等收入国家。 此外，据美国牙科协会称，到 2022 年 11 月，全球口腔疾病病例数将在过去 30 年中增加 10 亿。 随着牙科疾病的增加，预计对颧骨和翼骨植入物的需求将增加，从而推动市场增长。 此外，根据美国美学牙科学会的一项研究，到 2022 年 11 月，普通患者将在美容牙科手术上花费超过 10,000 美元。 预计如此高的美容牙科支出将增加对颧骨和翼状□肉植入手术的需求。 因此，在预测期内推动市场增长。

此外，正在举办许多关于颧骨和翼状□肉植入物的课程和研讨会以推进治疗，预计这将提高对这些植入物的认识，从而刺激市场的增长。。 例如，2022 年 6 月举行的 2022 年口腔重建基金会 (ORF) 国际研讨会将重点教育和培训更多牙医进行颧骨和翼状□肉种植体的 all-on-X 牙种植体手术。 此类课程和培训有望提高手术的效率和安全性，从而提高牙医对颧骨和翼状骨植入物治疗的认识，从而推动市场的增长。 因此，上述因素共同归因于预测期内研究的市场增长。 然而，与种植体相关感染相关的并发症发生率不断增加是製约市场增长的主要因素。

颧骨和翼状骨植入物的市场趋势

严重上颌骨萎缩预计将按应用占据主要市场份额

上颌骨严重萎缩部分预计将占据很大的市场份额。 当下颌骨开始恶化时，就会发生骨萎缩，也称为下颌骨坏死。 该细分市场的增长因素是上颌骨严重萎缩的发生率增加、老年人口增加以及市场参与者实施战略举措。 例如，根据《联合国2022年世界人口老龄化亮点》，2021年全球65岁及以上人口将达到7.71亿，预计2030年老年人口将达到9.94亿。 老龄化社会易患上颌骨吸收、骨量增加等牙科疾病。

此外，根据国家医学图书馆 2021 年 1 月发表的一篇文章，颧骨植入物是一种低成本、低并发症、低发病率、治疗时间短且相对便宜的正式植骨技术替代方法. 这些研究预计将提供高存活率，反映了对颧骨种植体的需求不断增加以治疗上颌骨严重萎缩，从而促进了该细分市场的增长。 此外，根据 Acta Odontologica Scandinavica 于 2021 年 12 月发表的一篇论文，与接受颧骨种植体支持的全口修復体相比，接受颧骨种植体支持的全口义齿修復的患者口腔健康相关生活质量显着改善，口腔健康相关生活质量显着改善。严重的上颌骨萎缩。对治疗表示总体满意。 此类研究证明了翼状□肉植入物的好处，并且由于其越来越多的采用，在预测期内推动了市场的增长。 因此，由于上述因素，预计该部分在预测期内将显着增长。

预计在预测期内欧洲将占据重要的市场份额

由于人口老龄化导致牙科疾病和伤害的发生率上升，以及颧骨种植手术对上颌骨吸收修復的好处，欧洲在全球颧骨和翼状□肉种植体市场占据主导地位。预计将占据很大的市场份额。 例如，根据联合国人口基金发布的2022年统计数据，德国、英国、法国和意大利估计有22%、19%、21%和24%的65岁及以上人口处于分别为 2022 年。 同样，根据欧洲牙周病学会的数据，牙周病是欧洲最常见的疾病。 35岁以上的人中，十个有八个患有牙周病。 此外，牙周病是成人和老年人口支出的主要原因。 因此，预计老年人口中牙科疾病的增加将推动市场的发展。

根据研究，颧骨和翼骨植入物的有效治疗似乎也推动了市场增长。 例如，国家医学图书馆 2021 年 6 月发表的一篇论文指出，颧骨和翼状□肉植入物已被提议作为欧洲重度吸收上颌骨康復的解决方案。 它还表明，进一步研究整个手术过程的准确性对于避免严重的手术并发症和外周解剖事故至关重要。 这种手术的优势有望推动市场增长。 这样，通过上述新兴市场的发展，该市场有望在欧洲实现显着增长。

其他福利。

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第一章介绍

• 研究假设和市场定义
• 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动力
  • 口腔疾病患病率增加，口腔卫生意识增强
  • 不断增长的老年人口
  • 对美容牙科的需求不断增长
• 市场製约因素
  • 植入物相关感染引起的并发症发生率高
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

• 按产品长度
  • 30 毫米或更小
  • 30 至小于 50 毫米
  • 50mm 或以上
• 通过使用
  • 上颌窦
  • 上颌骨严重萎缩
  • 其他用途
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东
    • 海湾合作委员会
    • 南非
    • 其他中东地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Straumann Holding AG
  • Noris Medical
  • S.I.N. Implant System
  • Southern Implants
  • IDC Implant & Dental Company
  • Danaher Corporation（NobelBiocare）
  • Titaniumfix
  • Implance
  • Bioline Dental Implants

第7章 市场机会今后动向

The zygomatic and pterygoid implants market is expected to register a CAGR of 5.9% over the forecast period.

The onset of COVID-19 presented a significant challenge for dentistry. The fear of getting infected with the virus and the postponement of dental surgery procedures and online consultation were the major factors that contributed to decreased visits to dental clinics. For instance, in March 2020, the American Dental Association (ADA) recommended that dental practices postpone elective dental procedures and provide emergency-only dental services to help keep patients from burdening hospital emergency departments. This subsequently leads to a decrease in demand for zygomatic and pterygoid implants, which has majorly affected the overall market. However, with the decline in COVID-19 cases and resumption of services, the studied market is expected to recover from the effect in the next two-three years.

The increasing prevalence of oral diseases, rising awareness about oral health, and growing demand for cosmetic dentistry are the major factors that are expected to drive the growth of the zygomatic and pterygoid implant market. For instance, as per November 2022 estimates of the WHO, oral diseases affected close to 3.5 billion people worldwide, with 3 out of 4 people affected living in middle-income countries. Furthermore, according to American Dental Association, in November 2022, the global cases of oral diseases have increased by 1 billion over the last 30 years. With such an increase in dental disease, the demand for zygomatic and pterygoid implants is expected to increase, driving growth in the market. Additionally, according to a survey by the American Academy of Cosmetic Dentistry, in November 2022, an average patient spent more than USD 10,000 on dental cosmetic procedure visits. Such high cosmetic dentistry spending is expected to increase the demand for zygomatic and pterygoid implant procedures. Thus, driving the market growth over the forecast period.

Furthermore, many courses and symposiums on zygomatic and pterygoid implants are being held for treatment advancements that are expected to increase the awareness about these impants and hence, adding to the growth of the market. For instance, in June 2022, the Oral Reconstruction Foundation (ORF) International Symposium 2022, made a concerted effort to educate and train more dentists on All-on-X dental implant procedures for zygomatic and pterygoid implants. Such courses and training are expected to increase the efficiency and higher safety of that procedure thus increasing awareness of zygomatic and pterygoid implant treatments among dentists and driving the growth of the market. Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However, the growing rate of complications linked to implant-associated infections is a major factor restraining the market's growth.

Zygomatic & Pterygoid Implants Market Trends

The Severe Atrophy of Maxillary Bone Segment is Expected to Hold a Major Share by Application in the Market

The severe atrophy of the maxillary bone segment is expected to hold a significant market share. Bone atrophy also referred to as osteonecrosis of the jaw occurs when the underlying jawbone begins to deteriorate. The factors contributing to the segment's growth are the increasing incidences of severe atrophy of the maxillary bone, the growing geriatric population, and the implementation of strategic initiatives by the market players. For instance, according to World Population Aging Highlight United Nations 2022, in 2022, there were 771 million people aged 65 years or over globally in 2021, and the older population is projected to reach 994 million by 2030. As the aging population is prone to suffering from dental ailments such as maxillary resorption and increased bone loss, the demand for zygomatic and pterygoid implants is expected to grow with the growing geriatric population.

Furthermore, as per a January 2021 published article by the National Library of Medicine, zygomatic implants appear to offer a promising alternative to formal bone grafting techniques with lower costs, fewer complications, less morbidity, shorter treatment times, and comparably high survival rates, such studies reflect the growing demand for zygomatic implants for severe atrophy of the maxilla, thereby contributing to the segment's growth. Additionally, according to an article published by Acta Odontologica Scandinavica, in December 2021, patients rehabilitated with zygomatic implant-supported complete dental prostheses showed substantial improvements in Oral health-related quality of life and general satisfaction with the treatment received by patients with severe maxillary bone atrophy. Such studies indicate the advantages of pterygoid implants which lead to growing adoption thus driving the growth of the market over the forecast period. Hence, due to the above-mentioned factors, the segment is expected to grow significantly over the forecast period.

Europe is Expected to Hold a Significant Share in the Market Over the Forecast Period

Europe is expected to hold a significant market share in the global zygomatic and pterygoid implants market due to the increase in the geriatric population leading to a rise in incidence rates of dental ailments & injuries and the advantage of zygomatic implant procedures for rehabilitation of resorbed maxillary bone. For instance, according to the 2022 statistics published by the United Nations Population Fund, Germany, the United Kingdom, France, and Italy estimated 22%, 19%, 21%, and 24% of the population respectively is aged 65 years and above in 2022. Likewise, according to the European Federation of Periodontology, in Europe, periodontal diseases are the most common conditions. Eight out of ten individuals aged over 35 years of age suffer from gum diseases. In addition, periodontal diseases represent a major cause of expenditure in the adult and geriatric population. Therefore, an increase in dental disease in the geriatric population is expected to drive the market.

The research studies suggest that effective treatment with zygomatic and pterygoid implants is also propelling the growth of the market. For instance, an article published by the National Library of Medicine, in June 2021, stated that zygomatic and pterygoid implants have been suggested as a solution to rehabilitate severely resorbed maxillary bone in Europe. It also suggested that further research on the accuracy of the entire procedure is mandatory to avoid critical surgical complications, which can involve accidents to the surrounding anatomy. Such an advantage of the procedure is expected to drive the growth of the market. Thus, due to the above-mentioned developments, the market is expected to witness significant growth in Europe.

Zygomatic & Pterygoid Implants Market Competitor Analysis

The zygomatic and pterygoid implants market is consolidated in nature due to the presence of a few major companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold significant market shares and are well-known, including Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants, and IDC Implant & Dental Company, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Oral Diseases coupled with Rising Awareness About Oral Health
  • 4.2.2 Increasing Geriatric Population
  • 4.2.3 Growing Demand for Cosmetic Dentistry
• 4.3 Market Restraints
  • 4.3.1 High Rate of Complications Linked to Implant-associated Infections
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Product Length
  • 5.1.1 Upto 30 mm
  • 5.1.2 30 - 50 mm
  • 5.1.3 Above 50 mm
• 5.2 By Application
  • 5.2.1 Maxillary Sinuses
  • 5.2.2 Severe Atrophy of Maxillary Bone
  • 5.2.3 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia Pacific
  • 5.3.4 Middle East
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Straumann Holding AG
  • 6.1.2 Noris Medical
  • 6.1.3 S.I.N. Implant System
  • 6.1.4 Southern Implants
  • 6.1.5 IDC Implant & Dental Company
  • 6.1.6 Danaher Corporation (NobelBiocare)
  • 6.1.7 Titaniumfix
  • 6.1.8 Implance
  • 6.1.9 Bioline Dental Implants

7 MARKET OPPORTUNITIES AND FUTURE TRENDS